Generic measures of health-related quality of life in ankylosing spondylitis: reliability, validity and responsiveness

被引:65
作者
Haywood, KL
Garratt, AM
Dziedzic, K
Dawes, PT
机构
[1] Coventry Univ, Sch Hlth & Social Sci, Physiotherapy & Dietet Subject Grp, Interdisciplinary Res Ctr Hlth, Coventry CV1 5FB, W Midlands, England
[2] Univ York, Dept Hlth Sci & Clin Evaluat, York YO1 5DD, N Yorkshire, England
[3] Univ Oxford, Inst Hlth Sci, Unit Healthcare Epidemiol, Oxford OX3 7LF, England
[4] Univ Keele, Dept Physiotherapy Studies, Keele ST5 5BG, Staffs, England
[5] Univ Keele, Primary Care Sci Res Ctr, Keele ST5 5BG, Staffs, England
[6] Staffordshire Rheumatol Ctr, Stoke On Trent ST6 7AG, Staffs, England
关键词
ankylosing spondylitis; generic instruments; patient-assessed health outcome; reliability; responsiveness; validity;
D O I
10.1093/rheumatology/41.12.1380
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To assess the acceptability and measurement properties of two generic measures of health-related quality of life (HRQL): the EuroQol and the Short Form 12-item Health Survey Questionnaire (SF-12) in ankylosing spondylitis (AS). Methods. Instruments were administered by means of a self-completed questionnaire to AS patients recruited from across the United Kingdom. Instruments were assessed for data quality and scaling assumptions. Test-retest reliability was assessed in those patients reporting no change in general health at 2 weeks. The convergent validity of both instruments was assessed and scores were correlated with responses to health transition questions. Responsiveness was assessed for patients reporting change in health at 6 months. Results. The instruments had high completion rates. Although slightly skewed towards better levels of health, scores covered the available range for both sections of the EuroQol [EQ-5D and EQ-visual analogue scale (EQ-VAS)]. Score distributions approximated normality for the SF-12. Test-retest reliability estimates support the use of both instruments in group evaluation and the SF-12 Physical Component Summary score (PCS) in individual evaluation (>0.90). Correlations between instruments were in the hypothesized direction and were of a moderate level. The EQ-VAS had the strongest linear relationship, with responses to both specific and general health transition questions (P<0.01). The EQ-VAS and SF-12 PCS were the most responsive instruments. The EQ-5D was the least responsive instrument. Conclusion. The instruments have undergone a comprehensive comparative evaluation to assess the measurement properties required for patient-assessed measures of health outcome in AS. Adequate levels of acceptability, reliability and validity were found for both instruments. Although evidence supporting instrument responsiveness was strong for the EQ-VAS and SF-12 PCS, it was very weak for the EQ-5D and SF-12 Mental Component Summary Scale (MCS). The EQ-VAS and SF-12 PCS can both be recommended for use in group evaluation, and the SF-12 PCS is recommended in routine practice or research. However, the lower reliability of the SF-12 MCS and the limited ability of both the EQ-5D and SF-12 MCS to detect change in health may restrict these roles.
引用
收藏
页码:1380 / 1387
页数:8
相关论文
共 28 条
[1]  
ABBOTT CA, 1994, BRIT J RHEUMATOL, V33, P1060
[2]   A comparative review of generic quality-of-life instruments [J].
Coons, SJ ;
Rao, S ;
Keininger, DL ;
Hays, RD .
PHARMACOECONOMICS, 2000, 17 (01) :13-35
[3]   REPRODUCIBILITY AND RESPONSIVENESS OF HEALTH-STATUS MEASURES - STATISTICS AND STRATEGIES FOR EVALUATION [J].
DEYO, RA ;
DIEHR, P ;
PATRICK, DL .
CONTROLLED CLINICAL TRIALS, 1991, 12 (04) :S142-S158
[4]  
DZIEDZIC K, 1998, RHEUMATOLOGICAL PHYS, P97
[5]  
FITZPATRICK R, 1993, BRIT J RHEUMATOL, V32, P807
[6]  
Fitzpatrick R, 1998, Health Technol Assess, V2, P1
[7]  
Garratt AM, 2001, J CLIN EPIDEMIOL, V54, P907
[8]  
GARRATT AM, 1997, THESIS U ABERDEEN UK
[9]  
GUYATT GH, 1989, CAN MED ASSOC J, V140, P1441
[10]   MEASURING HEALTH-RELATED QUALITY-OF-LIFE [J].
GUYATT, GH ;
FEENY, DH ;
PATRICK, DL .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (08) :622-629